IP Library Granted Patent US 8,014,857
Granted Patent B2
US 8,014,857 · App. 12/428,106 · Granted Sep 6, 2011

Implantable shock electrode line and implantable defibrillation arrangement

Assignee: Biotronik CRM Patent AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,014,857
App. No.
12/428,106
Granted
Sep 6, 2011
Kind
B2
Abstract

An implantable shock electrode line having a proximal terminal for connection to an implantable defibrillator, an elongated flexible line body, and a shock electrode and a drug delivery device arranged at or near the distal end of the line body. A drug depot connected to the drug delivery device is provided in the shock electrode line, and the terminal is designed as a purely electric standard terminal. The drug delivery device is designed for control by an electric pulse transmitted over the electric terminal to the shock electrode line.

Claims (65)

1. An implantable shock electrode line including an elongated line body extending between:

a. a proximal end bearing:

(1) an electric terminal, and

(2) a drug depot;

b. a distal end bearing:

(1) a shock electrode, the shock electrode being configured to deliver a shock upon receipt of an electric pulse transmitted from the electric terminal, and

(2) a drug delivery device including one or more piezoelectrically-driven pumps, the drug delivery device being configured to deliver a dose of a drug from the drug depot when the electric pulse is transmitted from the electric terminal to the shock electrode.

2. The shock electrode line of claim 1 wherein the terminal lacks any fluid conduits in communication with the drug delivery device.

3. The shock electrode line of claim 1 wherein two or more drug delivery devices are:

a. spaced along the distal end of the line body, and

b. configured to be triggered by pulses transmitted from the electric terminal which have different electrical qualities.

4. An implantable shock electrode line including:

a. an electric terminal,

b. an elongated line body extending from the electric terminal at a proximal line body end, and

c. a shock electrode at or near a distal line body end opposite the proximal line body end,

d. an electrically-actuated pump on the line body at or near the shock electrode,

e. a drug depot at or near the proximal line body end, the drug depot being connected to the pump via a fluid connection,

wherein the pump is configured to be triggered by an electric pulse transmitted from the electric terminal to the shock electrode.

5. An implantable shock electrode line including:

a. an elongated flexible line body extending between a proximal end and a distal end,

b. an electric terminal for connection to an implantable defibrillator at the proximal end,

c. a shock electrode at the distal end, and

d. a drug delivery device at the distal end, wherein the drug delivery device is configured to be triggered by an electric pulse transmitted from the electric terminal to the shock electrode.

6. The shock electrode line of claim 5 further including a drug depot:

a. at or near the proximal end, and

b. connected to the drug delivery device via a fluid connection.

7. The shock electrode line of claim 5 wherein the terminal lacks any fluid conduits.

8. The shock electrode line of claim 5 further including a drug depot:

a. being situated along the line body,

b. connected to the drug delivery device via a fluid connection, and

c. having a self-sealing wall configured to be refilled by means of an inserted injection needle.

9. The shock electrode line of claim 5 wherein the drug delivery device includes an electrically actuated pump.

10. The shock electrode line of claim 9 wherein the pump:

a. has a piezoelectric drive, and

b. is configured to be electrically actuated by an electric pulse transmitted from the electric terminal to the shock electrode.

11. The shock electrode line of claim 5 including two or more drug delivery devices situated along the line body.

12. The shock electrode line of claim 11 wherein the drug delivery devices are all:

a. connected in communication with the electric terminal, and

b. configured to be electrically actuated by an electric pulse transmitted from the electric terminal to the shock electrode.

13. The shock electrode line of claim 5 wherein:

a. two or more drug delivery devices are:

(1) spaced along the line body,

(2) each in fluid communication with a respective drug depot, and

(3) configured to be triggered by a pulse transmitted from the electric terminal, and

b. the different drug depots are configured to eject one or more of:

(1) different drugs, and

(2) different doses of drug.

14. The shock electrode line of claim 5 wherein the drug delivery device is configured to be triggered to release a drug only upon receipt of at least one of:

a. a voltage above a certain threshold level, and

b. a voltage of a certain polarity.

15. The shock electrode line of claim 5 including first and second drug delivery devices wherein:

a. the first drug delivery device is configured to be triggered to release a drug upon receipt of a first electrical signal, and

b. the second drug delivery device is configured to be triggered to release a drug upon receipt of a second electrical signal,

wherein the first and second electrical signals differ in their electrical qualities.

16. The shock electrode line of claim 15 wherein the first and second electrical signals differ in one or more of:

a. voltage, and

b. polarity.

17. The shock electrode line of claim 5 :

a. wherein the drug delivery device is configured to eject a set dose of a drug when triggered, and

b. further including a drug depot connected to the drug delivery device, wherein the drug depot holds several set doses of the drug.

18. The shock electrode line of claim 5 :

a. including two or more drug delivery devices, each being configured to be electrically actuated by an electric pulse transmitted from the electric terminal to the shock electrode, and

b. one or more of the drug delivery devices are configured to be selectively blockable whereby their actuation is prevented during transmission of the electric pulse from the electric terminal to the shock electrode.

19. The shock electrode line of claim 18 wherein one or more of the drug delivery devices are configured to be selectively blockable by a signal from a control line extending from the electrical terminal.

20. The shock electrode line of claim 18 wherein one or more of the drug delivery devices are configured to be selectively blockable by a magnetically-actuated switch.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2018
From: BIOTRONIK CRM PATENT AG
To: BIOTRONIK SE & CO. KG
Reel/Frame 045995/0948 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2009
From: DOERR, THOMAS
To: BIOTRONIK CRM PATENT AG
Reel/Frame 022581/0014 →
Priority Claims (1)
DE 10 2008 024 447 · May 20, 2008 · national
Continuity (1)
Related Publication 20090292330A1 · Nov 26, 2009